Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioClot is a specialized biotechnology company focused on the development and manufacture of high-quality reagents and diagnostic kits for the field of hemostasis and thrombosis. Based in Germany, the company provides a comprehensive portfolio of products including coagulation factor deficient plasmas, chromogenic substrates, and specialized antibodies for research and clinical diagnostics. BioClot serves a global market, supplying hospitals, clinical laboratories, and pharmaceutical research institutions with tools to monitor blood clotting disorders and anticoagulant therapies. Their expertise extends to the production of customized reagents and the distribution of specialized diagnostic platforms. The company is recognized for its technical proficiency in coagulation protein purification and assay development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioClot.